Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism NOX inhibitors(NADPH oxidase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dystrophy, Macular | Phase 1 | KR | 15 Apr 2022 | |
Wet age-related macular degeneration | Preclinical | KR | 01 Jun 2020 | |
Wet age-related macular degeneration | Preclinical | KR | 01 Jun 2020 |